Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
Pfizer
UM Funding ID
FD03655
Sponsor
Pfizer
Category
International
Description
This competitive program seeks to encourage organizations to submit grant applications for independent medical education initiatives that will result in the measurable improvement of the medical and scientific understanding of emerging treatment options for patients with Hemophilia.
Individual projects requesting up to $100,000 will be considered.
VPRI Contact
Elke Schattka
Research Contracts OfficerElke [dot] .Schattka [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | Ongoing 7 business days prior to due date by 4:30 pm CST | Ongoing Rolling due dates - please see RFP for details |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.